Topic Hub
29 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 29 of 29 clinical reviews.
A clinical comparison of the side-effect profiles of Ambien (zolpidem) and Belsomra (suvorexant), including trial data, risk categories, and switching guidance.
Read clinical reviewClinical comparison of Ambien (zolpidem) and Belsomra (suvorexant) for insomnia, including how to switch safely, efficacy data, side-effect profiles, and which patients benefit most from each drug.
Read clinical reviewA clinical comparison of zolpidem (Ambien) and lemborexant (Dayvigo) side effects, including next-day sedation, dependence risk, parasomnias, and tolerability data from key trials.
Read clinical reviewA clinical comparison of Ambien (zolpidem) and Lunesta (eszopiclone) side-effect profiles, including CNS effects, next-day impairment, taste disturbance, and long-term safety data from key trials.
Read clinical reviewA clinical comparison of zolpidem (Ambien) and eszopiclone (Lunesta) covering price, insurance coverage, generic availability, and prescribing access for insomnia treatment.
Read clinical reviewClinical comparison of zolpidem (Ambien) and eszopiclone (Lunesta) for insomnia, covering sleep onset latency, sleep maintenance, long-term efficacy data, dosing, and side effects.
Read clinical reviewClinical guide to switching between Ambien (zolpidem) and Lunesta (eszopiclone), including dose equivalence, tapering protocols, and head-to-head efficacy data for sleep onset and maintenance insomnia.
Read clinical reviewCompare the side-effect profiles of Ambien (zolpidem) and trazodone for insomnia. Review clinical trial data, next-day impairment risks, dependency potential, and tolerability differences.
Read clinical reviewCompare zolpidem (Ambien) and trazodone for insomnia side by side: pricing, insurance coverage, scheduling restrictions, and clinical evidence for each medication.
Read clinical reviewA clinical comparison of zolpidem (Ambien) and trazodone for insomnia, covering sleep onset, maintenance, side effects, dependency risk, and prescribing guidance.
Read clinical reviewA clinical comparison of zolpidem (Ambien) and trazodone for insomnia, including how to switch between them, efficacy data, side-effect profiles, and practical guidance for patients and prescribers.
Read clinical reviewA clinician-reviewed comparison of Belsomra (suvorexant) and Dayvigo (lemborexant) side-effect profiles, drawing on key trial data from Herring et al. and SUNRISE-1.
Read clinical reviewA head-to-head comparison of Belsomra (suvorexant) and Dayvigo (lemborexant) covering price, insurance formulary placement, patient assistance programs, efficacy data, and practical access strategies for insomnia treatment.
Read clinical reviewA detailed clinical comparison of suvorexant (Belsomra) and trazodone side effects, including CNS depression, next-day somnolence, cardiac risks, priapism, and weight changes, with trial data and FDA safety information.
Read clinical reviewA head-to-head comparison of Belsomra (suvorexant) and trazodone for insomnia, covering cost, insurance access, efficacy data, side effects, and switching protocols.
Read clinical reviewEvidence-based guide to switching between Belsomra (suvorexant) and trazodone for insomnia, covering pharmacology, wash-out timing, dose equivalence, and clinical protocols.
Read clinical reviewCompare the side-effect profiles of Dayvigo (lemborexant) and trazodone for insomnia. Evidence from SUNRISE-1 and clinical data on tolerability, next-day function, and safety risks.
Read clinical reviewCompare Dayvigo (lemborexant) and trazodone for insomnia treatment. Covers pricing, insurance coverage, efficacy data from SUNRISE-1 and off-label evidence, side effects, and access options.
Read clinical reviewCompare lemborexant (Dayvigo) and trazodone for insomnia treatment. Review SUNRISE-1 trial data, off-label evidence, efficacy endpoints, side effects, and which sleep medication works better.
Read clinical reviewClinical guidance on switching between Dayvigo (lemborexant) and trazodone for insomnia, including tapering protocols, pharmacologic differences, and what to expect during the transition.
Read clinical reviewA clinical comparison of Lunesta (eszopiclone) and Belsomra (suvorexant) side-effect profiles, covering dysgeusia, somnolence, complex sleep behaviors, next-day impairment, and switching considerations.
Read clinical reviewHead-to-head comparison of Lunesta (eszopiclone) and Belsomra (suvorexant) covering drug costs, insurance coverage, clinical efficacy, side effects, and switching considerations for chronic insomnia.
Read clinical reviewA clinical comparison of eszopiclone (Lunesta) and suvorexant (Belsomra) for insomnia, covering sleep onset, maintenance, safety profiles, and guideline recommendations.
Read clinical reviewA clinical comparison of Lunesta (eszopiclone) and Belsomra (suvorexant) covering mechanism, efficacy, side effects, and how to switch safely between these two insomnia medications.
Read clinical reviewA head-to-head comparison of eszopiclone (Lunesta) and lemborexant (Dayvigo) covering cost, insurance access, clinical efficacy, and safety for insomnia treatment.
Read clinical reviewComparing eszopiclone (Lunesta) and lemborexant (Dayvigo) for insomnia treatment. Evidence-based analysis of sleep onset, maintenance, next-day function, and safety profiles from clinical trials.
Read clinical reviewA clinical comparison of eszopiclone (Lunesta) and lemborexant (Dayvigo) side effects, including next-day residual effects, taste disturbance, dependency risk, and safety data from key trials.
Read clinical reviewCompare the side-effect profiles of Lunesta (eszopiclone) and trazodone for insomnia, including clinical trial data, tolerability differences, and practical switching guidance.
Read clinical reviewA clinical comparison of eszopiclone (Lunesta) and trazodone for insomnia, covering sleep onset latency, maintenance, side effects, and prescribing considerations backed by trial data.
Read clinical review